Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.71 is in line with its 5-year average of 5.52, around the middle of its 5-year range (0.74–13.84).
As of the fiscal period ended Tuesday, June 30, 2026. 23.23% below its 12-month average of 7.44.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.71.
CURRENT RATIO
5.71
CURRENT RATIO AVG TTM
7.44
CURRENT RATIO AVG 3Y
6.98
CURRENT RATIO AVG 5Y
5.52
CURRENT RATIO AVG 10Y
4.65
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-23.23%
CURRENT VS 3Y AVG
-18.16%
CURRENT VS 5Y AVG
+3.58%
CURRENT VS 10Y AVG
+22.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 699 covered companies
CURRENT VS SECTOR MEDIAN
+64.19%
vs the sector median at left
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$108.48M
Current Ratio
5.71
TTM Avg
7.44
3Y Avg
6.98
5Y Avg
5.52
Market Cap
$108.32M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$108.48M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$109.64M
Current Ratio
0.81
TTM Avg
0.51
3Y Avg
0.77
5Y Avg
1.23
Market Cap
$110.31M
Current Ratio
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
Market Cap
$110.95M
Current Ratio
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
Market Cap
$105.27M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $108.48M | 5.71 | 7.44 | 6.98 | 5.52 |
| Apyx Medical Corporation (APYX)vs › | $108.32M | 5.68 | 5.13 | 4.85 | 5.20 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.48M | 0.96 | 1.08 | 1.26 | 1.56 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.64M | 0.81 | 0.51 | 0.77 | 1.23 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $110.31M | 7.28 | 6.67 | 7.13 | 10.02 |
| Immunic, Inc. (IMUX)vs › | $110.43M | 5.05 | 1.26 | 3.56 | 6.57 |
| BGM Group Ltd. (BGM)vs › | $116.34M | 1.25 | 2.31 | 3.27 | 2.89 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.95M | 12.63 | 12.83 | 15.22 | 15.22 |
| Definitive Healthcare Corp. (DH)vs › | $105.27M | 1.86 | 1.97 | 2.28 | 2.24 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
Current Ratio
5.71
Quick Ratio
5.71
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.71 |
| 2026-03-31 | 7.92 |
| 2025-12-31 | 8.07 |
| 2025-09-30 | 6.31 |
| 2025-06-30 | 9.21 |
| 2025-03-31 | 11.82 |
| 2024-12-31 | 12.94 |
| 2024-09-30 | 13.84 |
| 2024-06-30 | 6.18 |
| 2024-03-31 | 4.69 |
| 2023-12-31 | 0.74 |
| 2023-09-30 | 0.99 |
| 2023-06-30 | 2.34 |
| 2023-03-31 | 3.19 |
| 2022-12-31 | 4.76 |
| 2022-09-30 | 3.86 |
| 2022-06-30 | 4.81 |
| 2022-03-31 | 5.85 |
| 2021-12-31 | 5.89 |
| 2021-09-30 | 6.51 |
| 2021-06-30 | 5.96 |
| 2021-03-31 | 5.52 |
| 2020-12-31 | 2.89 |
| 2020-09-30 | 2.06 |
| 2020-06-30 | 2.09 |
| 2020-03-31 | 1.58 |
| 2019-12-31 | 1.09 |
| 2019-09-30 | 1.88 |
| 2019-06-30 | 2.56 |
| 2019-03-31 | 1.78 |
| 2018-12-31 | 2.45 |
| 2018-09-30 | 3.45 |
| 2018-06-30 | 5.02 |
| 2018-03-31 | 7.25 |
| 2017-12-31 | 7.98 |
| 2017-09-30 | 6.00 |
| 2017-06-30 | 6.37 |
| 2017-03-31 | 7.21 |
| 2016-12-31 | 1.96 |
| 2016-09-30 | 2.99 |
| 2016-06-30 | 4.50 |
| 2016-03-31 | 2.49 |
| 2015-12-31 | 3.50 |
| 2015-09-30 | 7.07 |
| 2015-06-30 | 4.06 |
| 2015-03-31 | 9.34 |
| 2014-12-31 | 8.85 |
| 2014-09-30 | 12.31 |
| 2014-06-30 | 9.77 |
| 2014-03-31 | 0.30 |
| 2013-12-31 | 0.47 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
